Uncategorized

United States Patent & Trademark Office (USPTO) Rules in Smith & Nephew’s Favor and Confirms Patent Claims Infringed by Arthrex Inc.

ANDOVER, Mass., March 30 /PRNewswire-FirstCall/ — The United States Patent & Trademark Office (USPTO) overruled Arthrex’s validity challenges to the claims of a medical device patent exclusively licensed to Smith & Nephew (NYSE: SNNNews; LSE: SNNews) by Dr. John O. Hayhurst of Portland, Ore.

As part of its attempt to overcome the jury’s verdict against it, Arthrex initiated a standard re-examination proceeding with the USPTO to try to declare the patent invalid. The USPTO ruling confirms the validity of the claims of the patent that are infringed by Arthrex.
A jury determined last June that Arthrex Inc. (Naples, Fla.) willfully infringed this patent and awarded Smith & Nephew Endoscopy $14.7 million for infringement through the end of 2005. That amount was later increased by the Court for prejudgment interest and additional damages.

Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close
Themed By teapots